Professor Tales said of the project: We expect the outcome of this research study to increase our understanding of vascularrelated mild cognitive impairment and vascular dementia and to have a direct, positive influence on the development of reallife and clinically-relevant tests of brain function, such as those used for early diagnosis and for ...
After several infections with different strains of the virus, children acquire immunity to rotavirus. Babies and toddlers between 6-24 months of age are at greatest risk for developing severe disease from rotavirus infection. Adults sometimes become infected, but the resulting illness is usually mild.
Indications and Usage for Rotateq. 1  Rotateq1 is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, and G4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of Rotateq should be administered between 6 and 12 weeks of age [see Dosage and Administration (2)].